EUVIMEDAtrasti EUVIMED
Video/Audio

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Jeffrey L Schloßhauer, Sama Shamloo, Katja Schamrin, Jochen Imig

Journal of Visualized Experiments · 2025

DOI: 10.3791/67752 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2025. Written by Jeffrey L Schloßhauer and 3 co-authors. Institution: Chemical Genomics Centre of the Max Planck Society; Max Planck Institute of Molecular Physiology. Major MEDLINE topics: RNA, Long Noncoding, CRISPR-Cas Systems, Melanoma, Clustered Regularly Interspaced Short Palindromic Repeats. Cited 2 times so far (Crossref); 40 references.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Long non-coding RNAs (lncRNAs) represent a vast and functionally diverse class of RNA molecules, with over 100,000 predicted in the human genome. Although lncRNAs are less conserved across species compared to protein-coding genes, they play critical roles in gene regulation, chromatin interactions, and cancer progression. Their involvement in cancer makes them promising therapeutic targets. CRISPR interference (CRISPRi), utilizing catalytically inactive Cas9 fused with a transcriptional repressor such as KRAB-MeCP2, offers a precise method for targeting nuclear lncRNAs and assessing their functions. This study introduces a dual CRISPRi system using orthogonal CRISPRi technologies from Staphylococcus aureus and Streptococcus pyogenes based on dCas9-KRAB-MeCP2, optimized for combinatorial targeting of lncRNAs in human melanoma cells. The protocol facilitates combinatorial gene knockdown or synthetic lethal screening of lncRNA pairs, providing a novel tool for cancer research. By exploring synthetic lethality between lncRNAs, this approach can help identify lncRNA interactions critical for cancer cell survival, offering new therapeutic strategies. The dual system's functionality is demonstrated, highlighting its potential in identifying critical cancer-specific lncRNA interactions.

Subjects

MeSH terms (MEDLINE)

RNA, Long NoncodingCRISPR-Cas SystemsMelanomaClustered Regularly Interspaced Short Palindromic RepeatsHumansCell Line, TumorStreptococcus pyogenesStaphylococcus aureus

Substances

RNA, Long Noncoding

Authors and institutions

  • Chemical Genomics Centre of the Max Planck Society; Max Planck Institute of Molecular Physiology.
  • Chemical Genomics Centre of the Max Planck Society; Max Planck Institute of Molecular Physiology; jochen.imig@mpi-dortmund.mpg.de.

Cite

APA

Schloßhauer, J. L., Shamloo, S., Schamrin, K., & Imig, J. (2025). Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells. Journal of Visualized Experiments. https://doi.org/10.3791/67752

Vancouver

Schloßhauer JL, Shamloo S, Schamrin K, Imig J. Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells. Journal of Visualized Experiments. 2025. doi:10.3791/67752

BibTeX
@article{Schlohauer2025,
  author = {Schloßhauer, Jeffrey L and Shamloo, Sama and Schamrin, Katja and Imig, Jochen},
  title = {Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  doi = {10.3791/67752}
}
Start for free →